19 research outputs found
Thromboembolic events associated with cisplatin chemotherapy in patients with gastric and esophageal cancer: A single-institution experience.
No full textP1-265: Predictive utilisation and associated costs of bevacuzimab with chemotherapy in advanced NSCLC
No full text
Identifying driver mutations in squamous cell lung cancer (SCC): The Lung Cancer Genomics Ireland (LCGI) study.
No full textCost saving analysis of reduced-dose versus standard-dose bevacizumab in recurrent glioblastoma.
No full textImpact of somatic PIK3CA and ERBB family mutations on pathological complete reponse (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
No full textEffect of somatic mutations in the four genes of the HER family on occurrence in HER2-positive breast cancer, cell proliferation rates, and resistance to HER2-targeted therapies in vitro.
No full text
